Introducing ATTD Diabetes Talks: Long-Acting Insulin Uncovered

https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/a2/d0/2e/a2d02e38-ee60-a2a4-bf5c-e6d951b93b39/mza_3048579604930026653.jpg/600x600bb.jpg

ATTD: Advanced Technologies and Treatments for Diabetes

ATTD on UNLOK

41 episodes

6 days ago

ATTD is the leading forum for the latest in diabetes research, technology, and clinical innovation. This podcast offers two types of content for healthcare professionals: * ATTD Conference Catch-up: AI-generated episodes with key insights from expert presentations & research discussions. * Curated Series: Human-led conversations such as CGM in Focus (supported by Dexcom), ATTD Tech Connect (sponsored by Medtronic), and previously Long-Acting Insulin Uncovered (supported by Eli Lilly and Company). Whether you're a specialist, researcher, or industry leader, hit subscribe.

Life Sciences

Science

RSS

All content for ATTD: Advanced Technologies and Treatments for Diabetes is the property of ATTD on UNLOK and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Life Sciences

Science

https://d3t3ozftmdmh3i.cloudfront.net/staging/podcast_uploaded_episode/43275051/43275051-1750152276055-06620d074a1c2.jpg

Introducing ATTD Diabetes Talks: Long-Acting Insulin Uncovered

ATTD: Advanced Technologies and Treatments for Diabetes

2 minutes 11 seconds

4 months ago

Introducing ATTD Diabetes Talks: Long-Acting Insulin Uncovered

What’s next in long-acting insulin therapy? Find out in ATTD Diabetes Talks: Long-Acting Insulin Uncovered, a new podcast for healthcare professionals who want to stay ahead in diabetes care.

Hosted by Ginger Vieira and powered by ATTD, this series brings you real conversations with CDCESs, PharmDs, pediatric endocrinologists, and people living with diabetes.

We’ll dive into the latest trends, explore clinical benefits, discuss patient selection strategies, and share real-world success stories to help you apply new insights in your practice.

Subscribe now and join us as we uncover how long-acting insulin is shaping the future of diabetes management.